— Know what they know.
Not Investment Advice
Also trades as: COLO-B.CO (CPH) · $vol 24M · CBHD.DE (XETRA) · $vol 0M · CLPBF (OTC) · $vol 0M

CLPBY OTC

Coloplast A/S
1W: +4.6% 1M: -0.1% 3M: -14.1% YTD: -21.7% 1Y: -31.7% 3Y: -47.2% 5Y: -53.2%
$6.31
-0.25 (-3.81%)
 
Weekly Expected Move ±3.4%
$6 $6 $6 $6 $7
OTC · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 46 · $14.2B mcap · 143M float · 0.488% daily turnover · Short 51% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$14.2B
52W Range6.1-10.03
Volume16,395
Avg Volume700,414
Beta0.50
Dividend$0.28
Analyst Ratings
3 Buy 3 Hold 2 Sell
Consensus Buy
Company Info
CEOLars Soren Rasmussen
Employees16,741
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-01-13
Holtedam 1-3
Humlebæk 3050
DK
45 49 11 11 11
About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms